
Paclitaxel resistance increases oncolytic adenovirus efficacy via upregulated CAR expression and dysfunctional cell cycle control
Keywords: Ovarian cancer; Paclitaxel resistance; Adenovirus; Coxsackie adenovirus receptor; Cell cycle control